Browsing by Author Ku, Matthew

Showing results 1 to 3 of 3
PreviewIssue DateTitleAuthor(s)
Feb-2024Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesCampbell, AshleaTeh, BenjaminMulligan, StephenRoss, David MWeinkove, RobertGilroy, NicoleGangatharan, ShanePrince, Henry MilesSzer, JeffTrotman, JudithLane, StevenDickinson, MichaelQuach, HangEnjeti, Anoop KKu, MatthewGregory, GarethHapgood, GregoryHo, Phoebe JoyCochrane, TaraCheah, ChanGreenwood, MatthewLatimer, MayaBerkahn, LeanneWight, JoelArmytage, Tasman Diamond, PeterTam, Constantine SHamad, Nada
23-Nov-2024Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceBarraclough, AllisonTang, Catherine Lasica, MasaSmyth, ElizabethCirillo, MelitaMutsando, HowardCheah, Chan YKu, Matthew
25-Feb-2024Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectShaw, BrionyChung, ElizaWellard, CameronYoo, EdwardBennett, RoryBirks, CallumJohnston, AnnaCheah, Chan YHamad, NadaSimpson, JockBarraclough, AllisonKu, MatthewViiala, NicholasRatnasingam, SumitaArmytage, Tasman Cochrane, TaraChong, GeoffreyLee, DeniseManos, KateKeane, ColmWallwork, StephanieOpat, StephenHawkes, Eliza A